PTPA and neoplasm: Pharmacological inhibition of PP2A phosphatase activity by toxins or small molecule drugs, including okadaic acid and microcystin, causes cellular transformation (9, 10), raising the possibility that pharmacological re-activation of residual PP2A activity may have anti-tumor efficacy.